Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Large B-cell lymphoma with IRF4 rearrangement: six case reports and a literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35968590 | PubTator, text mining | PubMed |
| [Study of cytogenetics and molecular biology in typical and atypical immunophenotypic chronic lymphocytic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 35968589 | PubTator, text mining | PubMed |
| Molecular evolutionary process of advanced gastric cancer during sequential chemotherapy detected by circulating tumor DNA. | J Transl Med | 2022 | 35962408 | PubTator, text mining | PubMed |
| Identification of circulating immune landscape in ischemic stroke based on bioinformatics methods. | Front Genet | 2022 | 35957686 | PubTator, text mining | PubMed |
| DSMZCellDive: Diving into high-throughput cell line data. | F1000Res | 2022 | 35949917 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Hemophagocytic lymphohistiocytosis as an onset of diffuse large B-cell lymphoma: A case report. | Oncol Lett | 2022 | 35949601 | PubTator, text mining | PubMed |
| Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. | Dis Markers | 2022 | 35937947 | PubTator, text mining | PubMed |
| Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa. | Afr J Lab Med | 2022 | 35937760 | PubTator, text mining | PubMed |
| Receptor-ligand pair typing and prognostic risk model for papillary thyroid carcinoma based on single-cell sequencing. | Front Immunol | 2022 | 35935973 | PubTator, text mining | PubMed |
| Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia. | Hemasphere | 2022 | 35935606 | PubTator, text mining | PubMed |
| Treatment strategies for patients with diffuse large B-cell lymphoma. | Cancer Treat Rev | 2022 | 35933930 | PubTator, text mining | PubMed |
| A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. | Nat Commun | 2022 | 35933472 | PubTator, text mining | PubMed |
| Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. | Front Oncol | 2022 | 35928872 | PubTator, text mining | PubMed |
| Role of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the CART Era. | Front Immunol | 2022 | 35928819 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognosis for Tripartite Motif-Containing Genes in Breast Cancer. | Front Genet | 2022 | 35928444 | PubTator, text mining | PubMed |
| Clonal germinal center B cells function as a niche for T-cell lymphoma. | Blood | 2022 | 35921527 | PubTator, text mining | PubMed |
| Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma. | Cancer Commun (Lond) | 2022 | 35920016 | PubTator, text mining | PubMed |
| Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion. | Proc Natl Acad Sci U S A | 2022 | 35917353 | PubTator, text mining | PubMed |
| United we stand: Double targeting of CD79B and CD20 in diffuse large B-cell lymphoma. | Br J Haematol | 2022 | 35917107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=59